1-4 of 4
K. Hsu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD57+ NK CELLS ARE Increased In Patients With Multiple Myeloma and ARE Primed Effectors For ADCC, But NOT Natural Cytotoxicty

Andy K Hsu, PhD, Nick Gherardin, BSc Hons, Hang Quach, MBBS MD, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, H Miles Prince, MB, BS, FRACP, FRCPA, MRACMA, MD, David Ritchie, MBBS, FRACP, FRCPA, PhD, Paul Neeson, PhD
Journal: Blood
Blood (2013) 122 (21): 1904.
https://doi.org/10.1182/blood.V122.21.1904.1904
Published: 2013
Journal Articles

Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death

Mary C. Clark, Mabel Pang, Daniel K. Hsu, Fu-Tong Liu, Sven de Vos, Randy D. Gascoyne, Jonathan Said, Linda G. Baum
Journal: Blood
Blood (2012) 120 (23): 4635–4644.
https://doi.org/10.1182/blood-2012-06-438234
Published: 2012
Includes: Supplemental data
Journal Articles

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

Andy K. Hsu, Hang Quach, Tsin Tai, H. Miles Prince, Simon J. Harrison, Joseph A. Trapani, Mark J. Smyth, Paul Neeson, David S. Ritchie
Journal: Blood
Blood (2011) 117 (5): 1605–1613.
https://doi.org/10.1182/blood-2010-04-278432
Published: 2011
Includes: Supplemental data
Journal Articles

Killer Immunoglobulin-Like Receptor Ligand (KIR-Lig) Mismatched Natural Killer (NK) Cell Transfusions for Multiple Myeloma (MM).

J. Shi, MD, PhD, S. Szmania, BS, N. Rosen, BS, A. Moreno, BS, R. Walker, MD, B. DuPont, MD, K. Hsu, MD, L.A. Baxter-Lowe, PhD, J. Shaughnessy, PhD, B. Barlogie, MD, PhD, M. Cottler-Fox, MD, G. Tricot, MD, PhD, F. van Rhee, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3472.
https://doi.org/10.1182/blood.V106.11.3472.3472
Published: 2005